What is the main purpose of this 10-Q filing?

The 10-Q filing provides a comprehensive update on IDEXX Laboratories' financial performance and operational status for the third quarter of 1998. It's a crucial document for investors to assess the company's progress, profitability, and financial health.

Where can I find the detailed financial statements and analysis for IDEXX Laboratories for this period?

The detailed financial statements, management's discussion and analysis, and other critical information are located within the actual 10-Q document itself, identified in the directory listing as potentially the '-98-005837.txt' file. The provided text is only a directory listing.

What are the key financial metrics investors should look for in this report?

Investors should focus on revenue growth, net income, earnings per share, gross profit margins, operating expenses, cash flow from operations, and the company's overall liquidity and solvency as presented in the balance sheet. Any commentary on future outlook or significant business developments is also vital.

Does this filing indicate any significant changes or events for IDEXX Laboratories?

The provided directory listing does not contain details about significant changes or events. This information would be found in the Management's Discussion and Analysis section of the full 10-Q filing. Investors need to review the complete document to understand any material developments.

IDXX 10-Q Quarterly Report Q3 FY1998 — Revenue, Net Income, EPS

Summary

IDEXX Laboratories, Inc. filed its quarterly report (10-Q) for the period ending September 29, 1998, on November 11, 1998. The filing provides a snapshot of the company's financial performance and operations during the third quarter of 1998. As a company focused on veterinary diagnostics and services, investors would be keen to understand revenue trends, profitability, and any strategic developments impacting its market position. While the provided text is a directory listing and does not contain detailed financial statements or management's discussion and analysis, it confirms the filing of the report. Investors should refer to the actual 10-Q document (specifically the -98-005837.txt file mentioned) for comprehensive financial data, including revenue, net income, balance sheet items, and cash flows, as well as management's commentary on the business outlook and risks.

Key Highlights

1IDEXX Laboratories filed its 10-Q for the period ending September 29, 1998.
2The filing date was November 11, 1998.
3The report covers the third quarter of fiscal year 1998.
4The provided text is a directory listing of the SEC filing.
5The actual financial details and management discussion are contained within the full 10-Q document (e.g., -98-005837.txt).
6Investors should consult the full filing for critical financial performance information.

IDEXX LABORATORIES INC /DE Quarterly Report for Q3 Ended Sep 30, 1998

Summary

Key Highlights

Frequently Asked Questions